Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
2(17%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
2
17%
Ph not_applicable
2
17%

Phase Distribution

2

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Phase 1Safety & dosage
2(50.0%)
N/ANon-phased studies
2(50.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

83.3%

5 of 6 finished

Non-Completion Rate

16.7%

1 ended early

Currently Active

2

trials recruiting

Total Trials

12

all time

Status Distribution
Active(4)
Completed(5)
Terminated(1)
Other(2)

Detailed Status

Completed5
Not yet recruiting2
Recruiting2
unknown2
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
2
Success Rate
100.0%
Most Advanced
Phase 1

Trials by Phase

Phase 12 (50.0%)
N/A2 (50.0%)

Trials by Status

completed542%
not_yet_recruiting217%
recruiting217%
unknown217%
withdrawn18%

Recent Activity

Clinical Trials (12)

Drug Details

Intervention Type
DRUG
Total Trials
12